These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8020711)

  • 1. [The distribution of class-I HLA antigens in patients with multiple myeloma].
    Golenkov AK; Nazarova IN; Petrochenkov AN; Serova LD; Sibiriakova LG; Starkov AE
    Gematol Transfuziol; 1993 Feb; 38(2):10-2. PubMed ID: 8020711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I and class II antigens associated with multiple myeloma in southern Africa.
    Patel M; Wadee AA; Galpin J; Gavalakis C; Fourie AM; Kuschke RH; Philip V
    Clin Lab Haematol; 2002 Aug; 24(4):215-9. PubMed ID: 12181024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.
    Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH
    Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
    Menke DM; Horny HP; Griesser H; Atkinson EJ; Kaiserling E; Kyle RA
    J Clin Pathol; 1998 Jun; 51(6):432-7. PubMed ID: 9771441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HL-A antigen frequencies in myeloma.
    Mason DY; Cullen P
    Tissue Antigens; 1975 May; 5(4):238-45. PubMed ID: 50633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of HLA antigens in predicting the active course of multiple myeloma].
    Zaraĭskiĭ MI; Podol'tseva EI
    Ter Arkh; 1998; 70(7):42-6. PubMed ID: 9742635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients.
    Park MH; Kim YW; Yoon HI; Yoo CG; Han SK; Shim YS; Kim WD
    Am J Respir Crit Care Med; 1999 Feb; 159(2):526-9. PubMed ID: 9927368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G and lymphoproliferative disorders.
    Amiot L; Le Friec G; Sebti Y; Drénou B; Pangault C; Guilloux V; Leleu X; Bernard M; Facon T; Fauchet R
    Semin Cancer Biol; 2003 Oct; 13(5):379-85. PubMed ID: 14708718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group.
    Dubaniewicz A; Szczerkowska Z; Hoppe A
    Mayo Clin Proc; 2003 Apr; 78(4):436-42. PubMed ID: 12683696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis in Northern-West region of Russia: results of HLA-typing].
    Odinak MM; Bisaga GN; Kalinina NM; Akimov SB; Semilutskaia IB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):40-4. PubMed ID: 10709290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA class I and II antigens and diffuse toxic goiter].
    Kalinin AP; Kamynina TS; Zaretskaia IuM; Abramov VIu; Klinova EG; Karachintsev VI
    Ter Arkh; 1993; 65(3):81-5. PubMed ID: 8059394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
    Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
    J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of human leukocyte antigen and esophageal cancer in North of Iran.
    Ajami A; Rafiei A; Naghshvar F; Sedghei M; Elisay A; Hedayatizadeh-Omran A
    Pak J Biol Sci; 2009 Dec; 12(24):1585-8. PubMed ID: 20334121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of class I HLA antigens with invasive meningococcal disease].
    Holub M; Hobstová J; Prazák J; Pudil P
    Cas Lek Cesk; 1998 Oct; 137(19):598-600. PubMed ID: 9818472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma.
    Perosa F; Prete M; Luccarelli G; Dammacco F
    Br J Haematol; 2003 Jan; 120(1):36-43. PubMed ID: 12492574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between human leukocyte antigens and leprosy in the Turkish population.
    Koçak M; Balci M; Pençe B; Kundakçi N
    Clin Exp Dermatol; 2002 May; 27(3):235-9. PubMed ID: 12072016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I.
    Wu X; Shao Y; Tao Y; Ai G; Wei R; Meng X; Hou J; Han Y; Zhan F; Zheng J; Shi J
    Biochem Biophys Res Commun; 2011 Nov; 415(1):187-92. PubMed ID: 22033416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease.
    Gündogdu F; Islamoglu Y; Pirim I; Gurlertop Y; Dogan H; Arslan S; Sevimli S; Aksakal E; Senocak H
    J Heart Valve Dis; 2007 May; 16(3):293-9. PubMed ID: 17578051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.